menu
    • menu

    Company profile for Acorda Therapeutics

    NEW Drugs in Dev: 12
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Acorda Therapeutics is a publicly traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. We started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurologic...
    Acorda Therapeutics is a publicly traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. We started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. We have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Acorda TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    420 Saw Mill River Road, Ardsley, NY United States 10502
    Telephone
    Telephone
    1-800-367-5109
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.acorda.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/acorda-therapeutics-inc-
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Asia Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    Asia Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Merz Therapeutics Plans US Workforce Growth After $185M Asset Purchase
    Merz Therapeutics Plans US Workforce Growth After $185M Asset Purchase

    12 Jul 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/germanys-merz-plots-us-workforce-increase-ceo-eyes-further-acquisitions-following-185m-asset

    FIERCE PHARMA
    12 Jul 2024
    Share Share
    Merz wins $185m bid for bankrupt Acorda assets and increases US workforce by 50%
    Merz wins $185m bid for bankrupt Acorda assets and increases US workforce by 50%

    11 Jul 2024

    // PHARMACEUTICAL-TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/merz-wins-185m-bid-for-bankrupt-acorda-assets-and-increases-us-workforce-by-50/

    PHARMACEUTICAL-TECHNOLOGY
    11 Jul 2024
    Share Share
    Merz Therapeutics Closes $185M Asset Purchase Agreement with Acorda Therapeutics
    Merz Therapeutics Closes $185M Asset Purchase Agreement with Acorda Therapeutics

    10 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240710459851/en

    BUSINESSWIRE
    10 Jul 2024
    Share Share
    Acorda fights on with new Inbrija ad ahead of bankruptcy sale
    Acorda fights on with new Inbrija ad ahead of bankruptcy sale

    04 Jun 2024

    // Andrea Park FIERCE PHARMA

    https://www.fiercepharma.com/marketing/ahead-bankruptcy-sale-acorda-fights-new-inbrija-tv-spot

    Andrea Park FIERCE PHARMA
    04 Jun 2024
    Share Share
    US FDA declines to approve Supernus' Parkinson's combination again
    US FDA declines to approve Supernus' Parkinson's combination again

    09 Apr 2024

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-declines-approve-supernus-drug-device-combination-parkinsons-disease-2024-04-08/

    REUTERS
    09 Apr 2024
    Share Share
    Acorda files for bankruptcy, inks $185M asset deal to Merz
    Acorda files for bankruptcy, inks $185M asset deal to Merz

    03 Apr 2024

    // Zoey Becker FIERCE PHARMA

    https://www.fiercepharma.com/pharma/acorda-inks-185m-asset-deal-merz-therapeutics-files-bankruptcy-after-years-disappointing

    Zoey Becker FIERCE PHARMA
    03 Apr 2024
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search